Literature DB >> 32694415

Comparative performance of the laboratory assays used by a Diagnostic Laboratory Hub for opportunistic infections in people living with HIV.

Narda Medina1,2, Ana Alastruey-Izquierdo2, Danicela Mercado3, Oscar Bonilla3, Juan C Pérez3, Luis Aguirre1, Blanca Samayoa1, Eduardo Arathoon1,3, David W Denning4,5,6, Juan Luis Rodriguez-Tudela6.   

Abstract

OBJECTIVES: We evaluated the comparative performance of different assays used in a Diagnostic Laboratory Hub that linked 13 HIV healthcare facilities for the diagnosis of tuberculosis (TB), histoplasmosis, and cryptococcosis, and describing its functions in Guatemala compared with other National Reference Laboratories.
METHODS: The following diagnostic techniques were analyzed in 24 months (2017-2018) in a cohort of patients with HIV: smear microscopy, mycobacterial and fungal cultures, isolator blood culture, PCR assays, and antigen detection tests.
RESULTS: A total of 4245 patients were included, 716 (16.2%) had an opportunistic infection: 249 (34.7%) TB, 40 (5.6%) nontuberculous mycobacteria, 227 (31.7%) histoplasmosis, 138 (19.3%) cryptococcosis, and 62 (8.6%) had multiple opportunistic infections. Two hundred sixty-three [92.6%; 95% confidence interval (CI), 89-95.1] of TB cases were diagnosed by PCR. Urine antigen assay detected 94% (95% CI, 89-96) of the disseminated histoplasmosis cases. A lateral flow assay to detect cryptococcal antigen diagnosed 97% (95% CI, 93.3-98.7%) of the cryptococcal cases. In 85 patients (51.5%) with a cerobrospinal fluid sample, cryptococcal meningitis was diagnosed in 55 (64.7%), of which 18 (32.7%) were only detected by cryptococcal antigen.
CONCLUSION: Validated commercial antigen tests, as used in this program, should be the new gold standard for histoplasmosis and cryptococcosis diagnosis. In their absence, 35% of disseminated histoplasmosis and 32.7% of cryptococcal meningitis cases would have been missed. Patients with multiple opportunistic infections were frequently diagnosed and strategies should be designed to screen patients irrespective of their clinical presentation. In low resource settings, Diagnostic Laboratory Hubs can deliver quality diagnostics services in record time at affordable prices.

Entities:  

Year:  2020        PMID: 32694415     DOI: 10.1097/QAD.0000000000002631

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  4 in total

1.  Cryptococcal and Histoplasma Antigen Screening Among People With Human Immunodeficiency Virus in Ghana and Comparative Analysis of OIDx Histoplasma Lateral Flow Assay and IMMY Histoplasma Enzyme Immunoassay.

Authors:  Bright K Ocansey; Benjamin Otoo; Isabella Asamoah; Vincent Ganu; Kofi P Berko; Oluwakemi Oladele; Emmanuella A Amankwa; Bismark Opoku-Asare; Martin Agyei; Lawrence George; Fleischer C N Kotey; Chris Kosmidis; Peter Puplampu; Japheth A Opintan; David W Denning
Journal:  Open Forum Infect Dis       Date:  2022-06-03       Impact factor: 4.423

2.  Diagnosis of fungal opportunistic infections in people living with HIV from Guatemala and El Salvador.

Authors:  Diana Forno; Blanca Samayoa; Narda Medina; Eduardo Arathoon; Carlos Rodolfo Mejia; Remei Gordillo; Rolando Cedillos; Jose Rodas; Angela Ahlquist Cleveland; Tom Chiller; Diego H Caceres
Journal:  Mycoses       Date:  2021-09-29       Impact factor: 4.931

3.  Epidemiology and Mortality of Cryptococcal Disease in Guatemala: Two-Year Results of a Cryptococcal Antigen Screening Program.

Authors:  Narda Medina; Juan Luis Rodriguez-Tudela; Juan Carlos Pérez; Danicela Mercado; Oscar Bonilla; Eduardo Arathoon; Ana Alastruey-Izquierdo
Journal:  Microorganisms       Date:  2022-07-10

4.  Incidence of Histoplasmosis in a Cohort of People with HIV: From Estimations to Reality.

Authors:  Narda Medina; Juan Luis Rodriguez-Tudela; Luis Aguirre; Luis R Salazar; Osmar Gamboa; Oscar Bonilla; Juan C Pérez; Eduardo Arathoon; David W Denning; Ana Alastruey-Izquierdo
Journal:  Microorganisms       Date:  2021-12-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.